These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy. Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189 [TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP. Viaggi M; Dagrosa MA; Longhino J; Blaumann H; Calzetta O; Kahl SB; Juvenal GJ; Pisarev MA Appl Radiat Isot; 2004 Nov; 61(5):905-9. PubMed ID: 15308166 [TBL] [Abstract][Full Text] [Related]
5. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer. Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301 [TBL] [Abstract][Full Text] [Related]
6. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy. Dagrosa MA; Viaggi M; Kreimann E; Farías S; Garavaglia R; Agote M; Cabrini RL; Dadino JL; Juvenal GJ; Pisarev MA Thyroid; 2002 Jan; 12(1):7-12. PubMed ID: 11838734 [TBL] [Abstract][Full Text] [Related]
8. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy. Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618 [TBL] [Abstract][Full Text] [Related]
9. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine. Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398 [TBL] [Abstract][Full Text] [Related]
10. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy. Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448 [TBL] [Abstract][Full Text] [Related]
11. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA. Chou FI; Chung HP; Liu HM; Chi CW; Lui WY Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330 [TBL] [Abstract][Full Text] [Related]
12. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity. Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896 [TBL] [Abstract][Full Text] [Related]
13. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT. Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711 [TBL] [Abstract][Full Text] [Related]
14. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy. Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838 [TBL] [Abstract][Full Text] [Related]
15. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma. Morris GM; Micca PL; Coderre JA Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168 [TBL] [Abstract][Full Text] [Related]
16. BNCT of 3 cases of spontaneous head and neck cancer in feline patients. Rao M; Trivillin VA; Heber EM; Cantarelli Mde L; Itoiz ME; Nigg DW; Rebagliati RJ; Batistoni D; Schwint AE Appl Radiat Isot; 2004 Nov; 61(5):947-52. PubMed ID: 15308173 [TBL] [Abstract][Full Text] [Related]
17. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model. Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900 [TBL] [Abstract][Full Text] [Related]
18. L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy. Capuani S; Gili T; Bozzali M; Russo S; Porcari P; Cametti C; D'Amore E; Colasanti M; Venturini G; Maraviglia B; Lazzarino G; Pastore FS Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):562-7. PubMed ID: 18793958 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy. Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598 [TBL] [Abstract][Full Text] [Related]
20. Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma. Coderre JA; Glass JD; Fairchild RG; Micca PL; Fand I; Joel DD Cancer Res; 1990 Jan; 50(1):138-41. PubMed ID: 2293547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]